Equities

Delivra Health Brands Inc

Delivra Health Brands Inc

Actions
  • Price (CAD)0.04
  • Today's Change0.00 / 0.00%
  • Shares traded6.08k
  • 1 Year change+100.00%
  • Beta1.2148
Data delayed at least 15 minutes, as of May 03 2024 14:53 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Delivra Health Brands Inc. is a Canada-based company, which provides lifestyle, and health and wellness products to consumers and patients in regulated markets around the world. The Company's subsidiaries include Dream Water Global (Dream Water) and Delivra Corp. (Delivra). The Company’s portfolio features brands like Dream Water and LivRelief. Its Dream Water brand offers sleep aids in a range of formats and formulations. Dream Water produces convenient, travel-friendly, single-serving 2.5oz liquid sleep shots, sleep powder packets that consumers can take with or without water and gummies. Its LivRelief brand offers relief for conditions, such as joint and muscle pain, nerve pain, varicose veins, wound healing and sports performance.

  • Revenue in CAD (TTM)11.39m
  • Net income in CAD-1.11m
  • Incorporated2008
  • Employees--
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CanadaBis Capital Inc20.91m3.27m10.30m--3.171.272.550.49260.02370.02370.15140.05920.97781.909.81--15.27-20.5527.30-54.8652.50--15.62-26.610.55097.880.4948--90.44--630.61--238.08--
Telo Genomics Corp0.00-3.07m10.64m----8.87-----0.0468-0.04680.000.01690.00-------195.00-85.03-222.53-113.86------------0.0263-------33.66--24.41--
Medicure Inc21.69m-921.00k11.17m25.00--0.56138.950.5147-0.0893-0.08932.011.910.74862.524.36867,760.00-3.19-13.42-4.43-18.2864.4861.87-4.25-27.381.55-19.840.0266---5.94-5.71-167.55---28.82--
Valeo Pharma Inc54.29m-28.43m11.29m100.00------0.208-0.3255-0.32550.6249-0.47651.233.5312.39434,296.00-64.52-64.35-215.78-113.2221.3823.88-52.37-69.710.2974-1.333.51--94.3165.20-8.01--76.61--
Willow Biosciences Inc1.17m-13.03m12.00m19.00--3.44--10.24-0.105-0.1050.00940.02760.0944--5.2361,684.21-104.98---122.40-------1,111.69--2.18--0.3856--42.75--12.05------
Delivra Health Brands Inc11.39m-1.11m12.44m----3.3259.261.09-0.0044-0.00440.04230.0121.052.175.95---10.26-45.81-20.21-58.3456.2137.95-9.78-289.551.42-0.37890.346--20.3068.2697.37---56.72--
Indiva Ltd37.57m-4.92m12.64m142.00------0.3366-0.0305-0.03050.2223-0.00180.9936.028.32---13.00-29.67-22.26-48.2428.0020.37-13.09-48.060.4537-0.53271.02--9.21264.6055.01---33.00--
AEterna Zentaris Inc.6.15m-22.63m13.40m21.00--0.5388--2.18-4.66-4.661.275.120.09671.5119.14---35.58-26.24-40.64-30.3495.0683.68-368.01-300.318.00--0.0151---20.25-30.0627.17--16.12--
Data as of May 03 2024. Currency figures normalised to Delivra Health Brands Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.